What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

May 2025 saw several significant developments in the field of cardiology, including new regulatory approvals, long-term clinical trial data and important findings from late-breaking studies. This roundup highlights the latest updates across structural, interventional and heart failure therapies, with implications for ...

On April 25, 2025, the FDA approved the OmniaSecure defibrillation lead, a 1.6 mm, catheter-delivered, lumenless lead for right ventricular implantation. The small-diameter lead is designed to connect to an implantable defibrillator and treat ventricular tachyarrhythmias, ventricular fibrillation, and bradyarrhythmias, with LEADR trial data showing high implant success, safety, and electrical performance.

At #ACVC2025 in Florence, a study on out-of-hospital cardiac arrest (OHCA) highlighted the importance of early cardiopulmonary resuscitation (CPR). Researchers found that rapid CPR initiation, rather than the type of rescuer, significantly impacts survival outcomes. Delays in return of spontaneous circulation (ROSC) led to higher mortality risks.

Welcome to this issue of Heart International. As ever, we aim to provide our readers with the latest developments, insights, and evidence-based discussions in cardiovascular care. This edition is particularly poignant, as we begin with a heartfelt tribute to an ...

Forty-seven years ago, Andreas Gruentzig introduced ‘percutaneous transluminal coronary angioplasty’ (PTCA) as a new approach to treating symptomatic occlusive coronary artery disease.1 The mechanism of balloon angioplasty (BA) formed the foundation around which newer equipment and technologies were developed, including ...

As 2024 draws to a close, we’re celebrating a wonderful year of content. From insightful expert Q&As and peer-reviewed articles to conference highlights and a wealth of medical education, it’s been a year filled with content that we hope has been useful to our audience. We’ve had the privilege of connecting with leading experts and working alongside medical societies to support the cardiology community with high-quality, easily accessible content.

Tricuspid regurgitation (TR) is a frequent finding on echocardiography, with detection rates reaching up to 86% across the different ranges of severity, with moderate or greater TR being reported in at least 6–8% of patients.1–3 The prevalence of TR increases with age, ...